EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration

Natasha Fothergill-Misbah iD, Juzar Hooker, Judith Kwasa, Richard Walker

Movement Disorders Clinical Practice · 2024

DOI: 10.1002/mdc3.14192 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders Clinical Practice, 2024. Verfasst von Natasha Fothergill-Misbah und 3 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Parkinson Disease, Health Services Accessibility, Caregivers, Qualitative Research. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Economic and Social Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The accessibility of Parkinson's disease medicines is limited across sub‐Saharan Africa, which can have negative health, social and financial consequences for people with Parkinson's disease and their families. However, there is a stark gap in the literature regarding the impact of poor access to medicines on individuals.

Objectives

The study objective was to understand the accessibility of Parkinson's disease medicines in Kenya from the perspective of people with Parkinson's disease, their caregivers and neurologists.

Methods

In‐depth qualitative interviews were conducted with 55 people with Parkinson's disease, 23 caregivers and 8 neurologists to understand their experience regarding challenges with accessing Parkinson's disease medicines and the health, social and financial impact of poor availability and affordability.

Results

Medicines for Parkinson's disease were deemed to be largely unavailable and unaffordable across Kenya. People with Parkinson's disease, caregivers and neurologists expressed the financial burden caused by long‐term treatment in the absence of health insurance coverage. Further, barriers accessing medicines negatively impacted symptom control, social relations, and quality of life.

Conclusions

Access to Parkinson's disease medicines in Kenya is limited, with severe implications for symptom management and quality of life. People with Parkinson's disease should be able to access and afford the medicines they need to manage their condition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHealth Services AccessibilityCaregiversQualitative ResearchHumansKenyaMaleFemaleMiddle AgedAgedQuality of LifeAntiparkinson AgentsAdultNeurologists

Stichwörter der Autor:innen

Africaaccessaffordabilityavailabilitymedication

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Aga Khan University Hospital, Nairobi, Kenya.
  • Department of Medicine, University of Nairobi, Nairobi, Kenya.
  • Northumbria Healthcare NHS Foundation Trust, Newcastle upon Tyne, UK.

ORCID-Profile: Natasha Fothergill-Misbah

Förderung

  • Economic and Social Research Council

Zitieren

APA

Fothergill-Misbah, N., Hooker, J., Kwasa, J., & Walker, R. (2024). Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.14192

Vancouver

Fothergill-Misbah N, Hooker J, Kwasa J, Walker R. Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration. Movement Disorders Clinical Practice. 2024. doi:10.1002/mdc3.14192

BibTeX
@article{FothergillMisbah2024,
  author = {Fothergill-Misbah, Natasha and Hooker, Juzar and Kwasa, Judith and Walker, Richard},
  title = {Access to Medicines for Parkinson's Disease in Kenya: A Qualitative Exploration},
  journal = {Movement Disorders Clinical Practice},
  year = {2024},
  doi = {10.1002/mdc3.14192}
}
Kostenlos starten →